Argus downgraded UnitedHealth from Buy to Hold
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/11/2025 | $312.00 | Outperform → Neutral | Robert W. Baird |
| 5/21/2025 | $270.00 | Hold → Reduce | HSBC Securities |
| 5/19/2025 | $308.00 | Buy → Hold | TD Cowen |
| 5/14/2025 | Strong Buy → Mkt Perform | Raymond James | |
| 5/14/2025 | $350.00 | Buy → Neutral | BofA Securities |
| 4/22/2025 | $490.00 | Buy → Hold | HSBC Securities |
| 4/21/2025 | Buy → Hold | Argus | |
| 1/10/2025 | $595.00 | Hold → Buy | HSBC Securities |
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)
FWP - UNITEDHEALTH GROUP INC (0000731766) (Subject)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr
UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos
Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol
Robert W. Baird downgraded UnitedHealth from Outperform to Neutral and set a new price target of $312.00
HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00
TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00
AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "a" (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) recently issued senior unsecured notes. (See detailed list below.) The outlook assigned to these Credit Ratings (ratings) is negative. The proceeds from UnitedHealth Group's recent $3 billion debt issuance are expected to be used for general corporate purposes, including repayment of short-term borrowings, commercial paper and/or upcoming debt maturities. As of May 31, 2025, UnitedHealth Group had approximately $12.7 billion of short-term borrowings outstanding. Financial leverage at the end of first quarter 2025 was e
UnitedHealth Group (NYSE:UNH) today announced that it recently became aware of an unsolicited "mini-tender" offer by Tutanota LLC (Tutanota) to purchase up to 175,000 shares of UnitedHealth Group's common stock, representing significantly less than 1% of UnitedHealth Group's common stock outstanding. The offer price of $325.00 per share is conditioned on, among other things, the closing price per share of UnitedHealth Group's common stock exceeding $325.00 per share on the last full trading day before the offer expires. This means that unless this condition is waived by Tutanota, UnitedHealth Group shareholders who tender their shares in the offer will receive a below-market price. Tutano
AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companie